OCT 29, 2018 5:50 PM PDT

Immunity for All

WRITTEN BY: Nicholas Breehl

As bioinformatics tools continue to develop, researchers can utilize them as tools to look at data in great detail. One such example comes from a team of scientists at the Wellcome Sanger Institute have shown how genes involved in the immune response have varied activity between cells and species.

Cells will initiate immune responses when threatened by a pathogen. This first defense, or first-line, is known as the innate immune response. To be effective against pathogen clearance, the response must be aggressive; however, it cannot be too harmful otherwise, it will destroy the host tissue as well. A balance between the two ends of the spectrum must be accomplished.

How these constraints have shaped the evolution of innate immunity remains to be under-defined. The study described in the scientific journal Nature characterizes the innate immune response’s transcriptional divergence between species and variability in expression among cells.

Here, the team made use of bulk and single-cell transcriptomics in fibroblasts and phagocytes from difference species – cells involved in wound healing and the ingestion of foreign pathogens. The cells were stimulated with antigenic molecules to elicit responses. This allows the researchers to observe the architecture of the innate immune response.

The team was able to measure the activity of thousands of genes in over 250,000 individual cells using single-cell genomics technology to chart the evolution of antiviral and antibacterial immunity. It has previously been observed that many genes in the innate immune response have rapidly evolved in vertebrates. Pressure from pathogenic attacks is considered to be the reason for such high paced evolution.

The genes involved in the innate response include those that make cytokine and chemokine molecules. The team showed that these genes which have evolved rapidly across species also have highly variable activity in different cells within an individual’s tissue. The scientists suggest this may be a mechanism of self-preservation in the case that a pathogen manipulates these genes to avoid immune responses.

In contrast to these highly evolved genes, the team reveals other genes which are conserved between species, those involved in regulation of the immune response. These genes may be under tighter constraints because they are involved in many different functions within cells. The researchers believe these genes to be the main weakness when attacked by pathogens.

Dr. Sarah Teichmann, head of Cellular Genetics at the Wellcome Sanger Institute and senior author of the research remarked, “The power of DNA sequencing at the resolution of single cells means this kind of study is now possible. There are an estimated 37 trillion cells in the human body, each with the same genetic code. But individual cells behave differently; they use that genetic code differently. By studying cells, we can understand these fundamental building blocks of life and how they work together – including how they resist pathogens.”

The team suggests that the expression patterns observed across species and conditions have evolved as a mechanism for fine-tuned regulation to achieve an effective but balanced response.

Sources: Nature, Science Daily, YouTube

About the Author
You May Also Like
FEB 10, 2021
Immunology
Cross-Reactive Antibodies Don't Protect Against COVID
FEB 10, 2021
Cross-Reactive Antibodies Don't Protect Against COVID
Did you know that hundreds of viruses can cause the common cold? Rhinovirus, adenovirus, and coronavirus infections can ...
FEB 25, 2021
Immunology
Asthma Inhalers Slash Risk of COVID Hospitalization by 90 Percent
FEB 25, 2021
Asthma Inhalers Slash Risk of COVID Hospitalization by 90 Percent
For mild cases of COVID, doctors recommend the usual regimen for getting through a cold or flu: Staying hydrated and res ...
MAR 02, 2021
Immunology
Another Trick up Tumors' Sleeves Exposed
MAR 02, 2021
Another Trick up Tumors' Sleeves Exposed
Tumors have sneaky strategies for establishing themselves within healthy tissues, flourishing in plain sight of circulat ...
MAR 18, 2021
Drug Discovery & Development
New Cancer Immunotherapy Targets Genetic Alteration in All Cancers
MAR 18, 2021
New Cancer Immunotherapy Targets Genetic Alteration in All Cancers
Researchers have developed a prototype for a new kind of cancer immunotherapy. The therapy uses engineered T-cells to ta ...
MAR 23, 2021
Immunology
Assay Detects Antibodies in Asymptomatic COVID Carriers
MAR 23, 2021
Assay Detects Antibodies in Asymptomatic COVID Carriers
It is estimated that around one in five people infected with SARS-CoV-2 will not show any infection symptoms. Some of th ...
JUN 16, 2021
Immunology
Researchers Identify a Novel COVID Therapeutic Target and Mortality Predictor
JUN 16, 2021
Researchers Identify a Novel COVID Therapeutic Target and Mortality Predictor
Researchers at King’s College London have discovered a new antiviral target to combat COVID-19: the galectin-3-bin ...
Loading Comments...